Clinical Trial Update: Evaluation of the Efficacy and Safety of Entelon Tab. 150mg in Patients With Osteoarthritis of Knee [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating the efficacy and safety of Entelon 150 mg tablets in knee osteoarthritis has been completed with results posted in 2019.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Knee Osteoarthritis

Drugs mentioned

• Entelon 150 mg (unknown)

Snippet

Sponsor: Hanlim Pharm. Co., Ltd. | Conditions: Knee Osteoarthritis | Phase 3 | Status: COMPLETED | Results posted: 2019-06-24